Medicare covers genetic testing only for people already diagnosed with cancer, regardless of family history. For individuals with an inherited genetic mutation causing increased cancer risk, coverage of many screenings and risk-reducing interventions is prohibited...

Lawmakers recognized the importance of breast cancer screening when the Affordable Care Act (ACA) provided millions of women across the country with access to no-cost screening mammography. However, for women at increased risk of cancer due to family history or a genetic...

The Patent Eligibility Restoration Act (PERA) would overturn 150 years of Supreme Court precedent and allow patents on laws of nature, products of nature, and abstract ideas. In healthcare, this would:Endanger the significant progress made in precision medicineReduce...

Genetic counselors provide crucial information and expertise. But, did you know that these knowledgeable providers are not approved Medicare practitioners? Currently, Medicare beneficiaries face significant barriers in accessing genetic counselor services, as Medicare does...

Approximately 168,000 people in the U.S. are living with metastatic breast cancer (MBC), cancer that has spread beyond the breast to other parts of the body. Under current law, MBC patients are subject to a combined 29-month waiting period for Social Security Disability...

The Prostate-Specific Antigen (PSA) test is the most effective tool we have to detect prostate cancer, and, most instances of prostate cancer are initially detected with this test. By testing the PSA levels, we are able to detect possible signs of prostate cancer. The...